158 related articles for article (PubMed ID: 5756166)
1. [Experiences with sulfonylurea tolazamide in an out-patient clinic for diabetics].
Kanzler G; Trenkner G; Rausch-Stroomann JB
Arzneimittelforschung; 1968 Oct; 18(10):1345-8. PubMed ID: 5756166
[No Abstract] [Full Text] [Related]
2. [Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
Düntsch G
Arzneimittelforschung; 1970 Apr; 20(4):577-9. PubMed ID: 5467825
[No Abstract] [Full Text] [Related]
3. [Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
Düntsch G
Arzneimittelforschung; 1970 Apr; 20(4):575-9. PubMed ID: 5467824
[No Abstract] [Full Text] [Related]
4. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
Vogel G; Krummel E
Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514
[No Abstract] [Full Text] [Related]
5. Tolazamide in the treatment of diabetes mellitus: clinical experience and review of the literature.
Balodimos MC; Marble A
Curr Ther Res Clin Exp; 1971 Jan; 13(1):6-12. PubMed ID: 4992570
[No Abstract] [Full Text] [Related]
6. Comparision of chlorpropamide with tolazamide in the treatment of diabetes mellitus.
Sherwood G; Bressler R
Curr Ther Res Clin Exp; 1968 Aug; 10(8):399-405. PubMed ID: 4970053
[No Abstract] [Full Text] [Related]
7. [Clinical experimentation with a new hypoglycemic agent (glipizide)].
Forattini C
Minerva Med; 1972 Oct; 63(70):3816-21. PubMed ID: 4562437
[No Abstract] [Full Text] [Related]
8. [Use of tolinase (tolazamide) in diabetes mellitus].
Genes SG; Grinchenko TS; Lobanovskaia LI
Vrach Delo; 1969 Apr; 4():40-4. PubMed ID: 5373588
[No Abstract] [Full Text] [Related]
9. [Tolazamide in the control of diabetes mellitus].
Ramos JV
Prensa Med Mex; 1969; 34(1):66-7. PubMed ID: 5787505
[No Abstract] [Full Text] [Related]
10. The use of tolazamide in the treatment of diabetes mellitus.
Beidleman B; Prevatt AL; Palmer RC
J Fla Med Assoc; 1966 Mar; 53(3):191-3. PubMed ID: 5323398
[No Abstract] [Full Text] [Related]
11. [Clinical experiences with oral antidiabetic HB 419 (glibenclamide)].
Schöffling K; Petzoldt R; Althoff-Zucker C; Beyer J; Retiene K; Böhle E; Kunkel W
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1439-45. PubMed ID: 5394468
[No Abstract] [Full Text] [Related]
12. Value of tolazamide "'Tolanase') as an oral hypoglycaemic agent.
Tewari SN; Fletcher R
Br J Clin Pract; 1967 Sep; 21(9):455-6. PubMed ID: 4864489
[No Abstract] [Full Text] [Related]
13. [Biguanide treatment of diabetics. Effect on body weight--tolerance].
Klein W; Hole P; Dietzmann HB; Buding A
Munch Med Wochenschr; 1969 Nov; 111(48):2507-10. PubMed ID: 5396030
[No Abstract] [Full Text] [Related]
14. [Effect of tolazamide on serum cholesterol].
López Amor E; Lozano Castañeda O; Domenque L
Rev Invest Clin; 1966; 18(2):229-37. PubMed ID: 5973929
[No Abstract] [Full Text] [Related]
15. Tolanase - a sulphonylurea antidiabetic agent.
Drug Ther Bull; 1968 Mar; 6(7):27-8. PubMed ID: 5655488
[No Abstract] [Full Text] [Related]
16. [Treatment of diabetes mellitus with tolazamide].
Nava M; Mendoza M
Prensa Med Mex; 1967; 32(1):56-8. PubMed ID: 5633826
[No Abstract] [Full Text] [Related]
17. [Testing a new antidiabetic (Glibenclamid) in hospitalized and ambulatory diabetics].
Belser F; Brögli H; Constam G; Zollikofer H
Schweiz Rundsch Med Prax; 1970 Apr; 59(16):598-601. PubMed ID: 4997187
[No Abstract] [Full Text] [Related]
18. Glibenclamide in the management of diabetes mellitus. I.
Devlin JG; Manning K; Harty J
J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337
[No Abstract] [Full Text] [Related]
19. Oral sulphonylureas in the management of diabetes.
Jackson WP
S Afr Med J; 1971 Jan; 45(5):118-23. PubMed ID: 4925995
[No Abstract] [Full Text] [Related]
20. [Our experience with Daonil. A new oral hypoglycemic agent].
Rodriguez-Miñon JL; Arrieta F; Herrera JL
Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
